Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003133962 | SCV003812706 | likely pathogenic | not provided | 2022-06-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003778725 | SCV004583892 | pathogenic | Congenital dyserythropoietic anemia, type II; Cowden syndrome 7 | 2023-12-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg554Aspfs*33) in the SEC23B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SEC23B are known to be pathogenic (PMID: 19561605, 25044164). This variant is present in population databases (rs781770571, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with SEC23B-related conditions. ClinVar contains an entry for this variant (Variation ID: 2433272). For these reasons, this variant has been classified as Pathogenic. |